Logo image of ZSPC

ZSPACE INC (ZSPC) Stock Fundamental Analysis

NASDAQ:ZSPC - Nasdaq - US98980W1071 - Common Stock - Currency: USD

3.67  -0.53 (-12.62%)

After market: 3.8 +0.13 (+3.54%)

Fundamental Rating

1

ZSPC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 72 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of ZSPC have multiple concerns. ZSPC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZSPC had negative earnings in the past year.
ZSPC had a negative operating cash flow in the past year.
ZSPC Yearly Net Income VS EBIT VS OCF VS FCFZSPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

ZSPC has a Return On Assets of -211.42%. This is amonst the worse of the industry: ZSPC underperforms 91.67% of its industry peers.
Industry RankSector Rank
ROA -211.42%
ROE N/A
ROIC N/A
ROA(3y)-110.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZSPC Yearly ROA, ROE, ROICZSPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100

1.3 Margins

ZSPC has a Gross Margin (40.87%) which is comparable to the rest of the industry.
ZSPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZSPC Yearly Profit, Operating, Gross MarginsZSPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

ZSPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZSPC has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ZSPC has an improved debt to assets ratio.
ZSPC Yearly Shares OutstandingZSPC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
ZSPC Yearly Total Debt VS Total AssetsZSPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ZSPC has an Altman-Z score of -43.44. This is a bad value and indicates that ZSPC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ZSPC (-43.44) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -43.44
ROIC/WACCN/A
WACC14.87%
ZSPC Yearly LT Debt VS Equity VS FCFZSPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -10M -20M -30M -40M

2.3 Liquidity

A Current Ratio of 0.49 indicates that ZSPC may have some problems paying its short term obligations.
ZSPC's Current ratio of 0.49 is on the low side compared to the rest of the industry. ZSPC is outperformed by 80.56% of its industry peers.
A Quick Ratio of 0.39 indicates that ZSPC may have some problems paying its short term obligations.
With a Quick ratio value of 0.39, ZSPC is not doing good in the industry: 86.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.39
ZSPC Yearly Current Assets VS Current LiabilitesZSPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

ZSPC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.39%.
Looking at the last year, ZSPC shows a very negative growth in Revenue. The Revenue has decreased by -13.26% in the last year.
EPS 1Y (TTM)-67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.82%
Revenue 1Y (TTM)-13.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.8%

3.2 Future

ZSPC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.33% yearly.
ZSPC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.97% yearly.
EPS Next Y41.84%
EPS Next 2Y40.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.41%
Revenue Next 2Y19.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ZSPC Yearly Revenue VS EstimatesZSPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ZSPC Yearly EPS VS EstimatesZSPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ZSPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZSPC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZSPC Price Earnings VS Forward Price EarningsZSPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZSPC Per share dataZSPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

ZSPC's earnings are expected to grow with 40.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZSPC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZSPACE INC

NASDAQ:ZSPC (6/13/2025, 8:00:02 PM)

After market: 3.8 +0.13 (+3.54%)

3.67

-0.53 (-12.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)N/A N/A
Inst Owners8.24%
Inst Owner Change559.74%
Ins OwnersN/A
Ins Owner Change0%
Market Cap83.97M
Analysts84.44
Price Target10.88 (196.46%)
Short Float %2.04%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.45%
Min Revenue beat(2)-12.93%
Max Revenue beat(2)31.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.03%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)3.81%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.75%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS1.67
BVpS-0.86
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -211.42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.87%
FCFM N/A
ROA(3y)-110.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover3.87
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 144.44%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.39
Altman-Z -43.44
F-Score4
WACC14.87%
ROIC/WACCN/A
Cap/Depr(3y)48.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.82%
EPS Next Y41.84%
EPS Next 2Y40.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.8%
Revenue Next Year-1.41%
Revenue Next 2Y19.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.44%
OCF growth 3YN/A
OCF growth 5YN/A